Chinese Pharmaceutical Manufacturer Lodges in Hagerie-Mariam

The Company invested 20 million dollars for the plant which will manufacture 30 varieties

Humanwell Pharmaceutical Ethiopia Plc, a Chinese owned company, has set up a new pharmaceutical plant in Hagerie-Mariam, Amhara Regional State with a 20 million dollar investment.

Lying on seven hectares of the land, the Plant will produce 30 varieties of medicines in four dosage forms: tablets, capsules, injections and syrups.

In August 2015, the project leader of the Company led the team into Ethiopia for the preparation of Ethiopian Humanwell. On January 22, 2016, it signed the land lease contract with Amhara Regional State, and on June 3, 2016, the cornerstone was laid.

The full project is worth 100 million dollars and will be executed in three phases accommodating a total of 1,000 employees. The Company finalised the construction of the first phase, and will be inaugurated on December 3,2017 in the presence of Gedu Andargachew, president of the regional state and Mebrhatu Meles (PhD), state minister for Industry.

The remaining two phases are expected to be completed within three or four years with 30 million dollars and 50 million dollars, respectively.

“But, we will execute phase two and three depending on the condition of the market,” said  Lu Xian Jun, integrated management head at the Company.

The phase one project was constructed and consulted by Chinese state companies for the past year and a half.

The Company, which imports the raw materials from India and China, is currently discussing with domestic distributors on the supply system, according to Lu.

Founded in 1993 and headquartered in China, Humanwell is active in over 10 countries, having an annual turnover of 1.5 billion dollars. Its main products are anaesthetics, fertility regulation and Uygur medicines. It engages in manufacturing and providing healthcare solutions. It has a presence in Mali, the United States (US) and Asia.

After meeting the local demand, Humanwell also targets to export its products to Kenya and Djibouti.

“The opening of the new plant will be useful in reducing the burden of foreign currency to import pharmaceutical supplies,” said Dessalegn Fanta, general manager and owner of the Medicor Africa Plc, a firm engaged in supplying pharmaceuticals, medical equipment, instruments and laboratory machines.

Yearly, the government procures pharmaceuticals worth over six billion Birr and receives a similar amount of pharmaceuticals from development partners.

These medicines are distributed to 304 pharmacies, 250 drug shops and 1,950 rural drug vendors, of which about 95pc are privately owned, data from World Health Organisation (WHO) indicates.

Currently, there are over 258 pharmaceutical products’ and medical equipment suppliers. The local industry comprises of 22 pharmaceutical and medical suppliers and producers, with nine involved directly in the manufacturing of pharmaceutical products. These local manufacturers supply only about 20pc of the domestic demand.


Published on Dec 07,2017 [ Vol 18 ,No 919]



For a nation that is growing by above average levels – even by th...


The black market for hard currencies operates outside the rules and reg...


The city of Addis Abeba is the most relegated membe...


Foreign currency shortage forced the government to take measures, such...


Ethiopia has gone through multiple regimes in its long history. Some of...


One has to be a cynic to miss the ray of hope that signaled a democrati...

View From Arada

The lack of maintenance in parts of the city that have cultural and his...

Editors Pick